Descargar PDF

Otros usuarios también vieron estos artículos

Novel desensitization therapy of mesalamine intolerance in patients with ulcerative colitis Kenji Kinoshita; Shintaro Sawaguchi; Kai Toyoshima; Sonoe Yoshida; Takahiro Yamamura; Kosuke Nagai; Ikko Tanaka; Kazuteru Hatanaka; Yoshiya Yamamoto; Hirohito Naruse; Takehiko Katsurada; Naoya Sakamoto;
Gastroenterol Hepatol. 2025;48:
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH¿AEG¿SEPD¿SEOM¿GETECCU Mar Riveiro-Barciela; Sabela Carballal; Álvaro Díaz-González; Míriam Mañosa; Javier Gallego-Plazas; Joaquín Cubiella; Paula Jiménez-Fonseca; María Varela; Luis Menchén; Bruno Sangro; Ana Fernández-Montes; Francisco Mesonero; Miguel Ángel Rodríguez-Gandía; Fernando Rivera; María-Carlota Londoño;
Gastroenterol Hepatol. 2024;47:401-32
Vedolizumab-induced cholestatic liver injury María Rojas-Feria; Miguel Rodríguez-Fernández; Manuel Castro-Fernández; Emilio Suárez-García;
Gastroenterol Hepatol. 2022;45:64-5